CARDINAL HEALTH INC
10-K, EX-10.17, 2000-09-06
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: CARDINAL HEALTH INC, 10-K, EX-10.16, 2000-09-06
Next: CARDINAL HEALTH INC, 10-K, EX-10.18, 2000-09-06



<PAGE>   1
                                                                   EXHIBIT 10.17





July 25, 2000


John C. Kane
2205 Wingate Drive
Delaware, OH  43015

Re:   Agreement Concerning Retirement

Dear John:

This letter confirms our agreement as of February 1, 2000 respecting your
retirement as Chief Operating Officer ("COO") of Cardinal Health, Inc.
("Company"), as follows:

1.    DUTIES/TITLE

      a)    Effective February 9, 2000, you will become Vice Chairman of the
            Board, in addition to President, COO and a Director. You will remain
            COO and President until the earlier of (i) the date on which your
            successor has commenced work, or (ii) December 31, 2000 (the "Search
            Period").

      b)    Upon conclusion of the Search Period, you shall relinquish the
            President and COO positions, but may remain an employee of the
            Company for a period of 12 months (the "Transition Period"). During
            the Transition Period, you shall be an executive in transition
            available up to 10 days per month (inclusive of any time necessary
            to attend Board of Directors meetings and meetings of Board
            Committees) to perform such tasks and pursue such projects of an
            executive nature as the CEO of the Company shall assign, if any, in
            the CEO's sole discretion.

      c)    At any time, upon request of either the Chairman or the Board, you
            shall tender your resignation as Vice Chairman and a Director.

      d)    At any time before, or upon conclusion of, the Transition Period,
            you, at your election, may either (i) immediately "retire" within
            the meaning of the Company's various incentive and welfare plans, in
            which case all duties required of you and all compensation and
            benefits payable to you, other than vested benefits and, in
            accordance with their terms, previously granted stock based
            incentives (collectively, the "Prior Entitlements"), shall cease and
            the "Retirement Period" shall commence, or (ii) elect to remain a
            consulting executive employee of the Company in a consulting
            capacity for a period of up to two years (the "Consulting Period")
            at an annual salary of $50,000 per year. In either case, you may
            pursue other employment, so long as the requirements of Section 4
            below are observed.


<PAGE>   2


            If you have not earlier elected to retire, upon the conclusion of
            the Consulting Period, you agree to and shall retire and the
            "Retirement Period" shall commence.

2.    TERMINATION/DEATH/DISABILITY

      a)    You may terminate your employment with the Company at any time, but
            in such event any compensation or benefits payable hereunder, other
            than the Prior Entitlements, shall cease although you shall remain
            bound by the terms of Section 4 below.

      b)    Should the Company, in its discretion, elect to terminate your
            employment at any time prior to the end of the Transition Period,
            you may exercise your rights under Section 1(d) above and shall
            retain any rights you may have to any Prior Entitlements, provided
            however that should you elect to retire at the time of such
            termination, you shall no longer be bound by the non-competition and
            non-hiring/non-solicitation restrictions contained in Sections 4(a)
            and 4(b) below.

      c)    If you die or become incapacitated prior to retirement such that you
            cannot perform the essential functions of your position with or
            without reasonable accommodation, you shall not receive any further
            compensation or benefits other than long term disability coverage
            and the Prior Entitlements.

3.    COMPENSATION/INCENTIVES/BENEFITS

      a)    Upon execution of this letter and through the Search Period, you
            shall remain at your current rate of pay with such duties,
            perquisites and benefits as you currently enjoy as President and
            COO. Upon commencement of the Transition Period, your annual salary
            shall become $750,000, payable on the same terms and conditions as
            salaries of other corporate executives of the Company. Upon
            commencement of the Consulting Period, if any, your annual salary
            shall become $50,000, payable on the same terms and conditions as
            salaries of other corporate executives of the Company. Upon
            commencement of the Retirement Period, all compensation and benefits
            payable to you, other than the Prior Entitlements, shall cease and
            your rights and benefits shall be limited to those of a retiree of
            the Company.

      b)    With respect to the Company's 2000 fiscal year, you shall be
            eligible to receive an annual bonus at such a percentage and upon
            such terms and conditions as those applicable to other, similarly
            situated, bonused executives. If the Search Period ends during
            fiscal year 2001 of the Company, you shall be eligible to receive a
            pro-rated bonus for such year. Other than this, you shall receive no
            further bonuses at any time.

      c)    As of February 9, 2000, you shall receive a non-qualified option
            grant in the amount of 50,000 shares (the "Final Grant").

      d)    During the Transition Period and the Consulting Period, if any, you
            may use Company aircraft on an as-available basis while pursuing
            company business.



                                       2
<PAGE>   3


            This use of aircraft may include any necessary commuting to Company
            offices. In addition, during such periods, all travel expenses you
            incur in pursuit of Company business shall be reimbursed.

4.    RESTRICTIONS

      a)    During the "Restricted Period" (defined below) you shall not engage
            with or invest in, counsel or advise or be employed by any
            enterprise which competes with the Company by developing,
            manufacturing or selling any product or service of a type,
            respectively, developed, manufactured or sold by the Company or any
            subsidiary thereof. The "Restricted Period" means the period ending
            on December 31, 2001 unless you have elected to remain a consulting
            employee of the Company, in which case the Restricted Period shall
            end when the Consulting Period ends.

      b)    During the Restricted Period, you shall not, without prior written
            consent of Company, directly or indirectly, solicit or hire any
            person who was or is at any time during the preceding three months
            an employee of the Company or any of its affiliates.

      c)    At all times, you agree to maintain as confidential all secret or
            confidential information of the Company and any of its affiliates
            and you agree never to divulge same unless compelled to do so by
            court order.

      d)    At all times, you agree to refrain from actions or statements,
            written or oral, which disparage the Company, its affiliates or any
            of their senior management. You also agree to refrain from any
            action which has the effect of interfering with the Company's or any
            of its affiliates' relationships with their customers.

      e)    In addition to all other limitations and conditions, receipt and
            continued vesting and exercisability of all of your stock-based
            incentives, including the Final Grant, are conditioned upon your
            continuing observance of the provisions of this Section 4 and, in
            the event of a breach of any such provision, any gains achieved by
            you with respect to any such incentives shall be subject to clawback
            as provided in the Final Grant. In addition, the Company may seek
            injunctive relief to enforce the provisions of this Section 4.



                                       3
<PAGE>   4



5.    ANNOUNCEMENT OF DEPARTURE

      Your retirement from your positions as COO, Vice Chairman or Director may
      be announced in a Company press release at such time and in such manner as
      you and the Company may mutually agree.

6.    MISCELLANEOUS

      a)    This Agreement shall be governed by Ohio law and all legal actions
            or proceedings, including those brought under Section 4 of this
            letter, shall be brought only in federal or state courts in Franklin
            County, Ohio. The prevailing party in any such case may recover
            attorneys' fees and costs from the loser. In addition, this
            Agreement shall be severable, and either party's failure to insist
            upon strict compliance shall not be deemed a waiver. This Agreement
            is our entire agreement and may only be amended in writing.

      b)    You and the Company agree to execute, simultaneous herewith, a
            mutual release in the form attached as Exhibit "A", so as to comply
            with the provisions of the Older Worker Benefit Protection Act.

If this letter correctly states our agreement, I would ask that you execute one
of the enclosed originals and return it to me.


                                       Very truly yours,


                                       /s/ Robert D. Walter
                                       Robert D. Walter
                                       Chairman of the Board and
                                       Chief Executive Officer


ACCEPTED AND AGREED:


/s/ John C. Kane
----------------------------------
John C. Kane



                                       4


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission